OncoMed Pharmaceuticals, Inc.

Surrozen Inc. thinks it has found a way around some of the issues of targeting the Wnt receptor and hopes its partnership with Boehringer Ingelheim GmbH may demonstrate that its bispecific antibodi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Novo/Fauna Partnership Inclu

Halozyme Therapeutics Inc. ’s only clinical drug candidate PEGPH20 will exit the stage – along with the company’s oncology operations – now that the drug has failed to show an improvement in overall s

With their summer vacations behind them, three biopharmaceutical companies returned from the long Labor Day weekend in the US with big funding announcements – Achilles Therapeutics Ltd. , NKarta The